Form 4: Palisade Bio Director Buys 5,000 Shares
Insider Transaction Report
Palisade Bio Director Donald Allen Williams purchased 5,000 shares of common stock at $1.6712 per share, increasing his direct beneficial ownership.
Summary
- Donald Allen Williams, a Director of Palisade Bio, Inc. (PALI), reported a transaction involving the company's common stock.
- The transaction, dated January 16, 2026, involved the acquisition of 5,000 shares of common stock.
- The shares were purchased at a price of $1.6712 per share.
- Following this transaction, Mr. Williams directly beneficially owns 10,728 shares of common stock.
- Additionally, Mr. Williams indirectly beneficially owns 3,000 shares of common stock through his Defined Benefit Plan.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged purchase.
Sentiment
Score: 7
Explanation: The purchase of company stock by a director generally indicates a positive outlook on the company's future performance and valuation, contributing to a moderately positive sentiment.
Positives
- A Director's purchase of company stock signals confidence in the company's future prospects and valuation.
- The transaction was executed under a Rule 10b5-1 plan, suggesting a pre-meditated investment decision rather than a reaction to immediate market events.
Related Party Transactions
- Director Donald Allen Williams acquired 5,000 shares of Palisade Bio, Inc. common stock at $1.6712 per share.
Stakeholder Impact
- Shareholders may view this insider purchase as a positive signal, potentially increasing confidence in the company's stock.
- The transaction demonstrates management's alignment with shareholder interests through direct investment in the company.
Key Dates
| Date | Description |
|---|---|
| 01/16/2026 | Transaction Date: Acquisition of 5,000 shares of common stock by Director Donald Allen Williams. |
| 01/21/2026 | Filing Date: SEC Form 4 filed. |
Recommendation
buyThe purchase of company stock by a director, especially under a pre-arranged 10b5-1 plan, suggests strong insider confidence in the company's long-term value and future prospects. This action by a key insider can be interpreted as a positive indicator for potential investors, warranting a 'buy' recommendation based on this signal of conviction.
Keywords
Palisade Bio, PALI, Insider Trading, Form 4, Stock Purchase, Director, Beneficial Ownership, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.